ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PMN ProMIS Neurosciences Inc

休市中 03-27 16:00:00 EDT

14.74

-0.39

-2.58%

盘后14.74

+0.000.00%

19:39 EDT

最高15.34	最低14.26	成交量3.17万
今开14.79	昨收15.13	日振幅7.14%
总市值1.32亿	流通市值1,503万	总股本896.77万
成交额46.88万	换手率3.11%	流通股本101.99万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":14.74,"timestamp":1774641600000,"preClose":15.13,"halted":0,"volume":31679,"hourTrading":{"tag":"盘后","latestPrice":14.74,"preClose":14.74,"latestTime":"19:39 EDT","volume":23,"amount":348.226,"timestamp":1774654753500,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025776602775941872,"floatShares":1019940,"shares":8967700,"eps":-22.61,"marketStatus":"休市中","change":-0.39,"latestTime":"03-27 16:00:00 EDT","open":14.785,"high":15.34,"low":14.26,"amount":468782.29395200004,"amplitude":0.071381,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-22.61,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":15.13,"preHourTrading":{"tag":"盘前","latestPrice":15.13,"preClose":15.13,"latestTime":"08:00 EDT","volume":20,"amount":302.6,"timestamp":1774612806641,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":14.74,"preClose":14.74,"latestTime":"19:39 EDT","volume":23,"amount":348.226,"timestamp":1774654753500,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6946741357843418},"requestUrl":"/m/hq/s/PMN","defaultTab":"news","newsList":[{"id":"2618134563","title":"Promis Neurosciences Inc.盘中异动 急速下挫6.64%报20.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618134563?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:34","pubTimestamp":1773243263,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时34分，Promis Neurosciences Inc.股票出现波动，股价急速下跌6.64%。截至发稿，该股报20.25美元/股，成交量1.4975万股，换手率0.70%，振幅8.39%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1920.80%、1036.25%、65.89%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、天演药业、Kala Bio, Inc.，振幅分别为62.07%、56.62%、50.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311233423a461a532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311233423a461a532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"1163920950","title":"ProMIS Neurosciences：募资所得预计将助力完成具有里程碑意义的1b期阿尔茨海默病研究，并支持关键临床里程碑的推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1163920950","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163920950?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:05","pubTimestamp":1769778312,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc (PMN) 近日宣布，其通过融资所获得的资金预计将为公司完成其具有里程碑意义的1b期阿尔茨海默病（AD）研究提供关键支持。这笔资金还将用于推动公司实现其他重要的临床开发里程碑，为公司后续的临床进展和管线发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"2607264724","title":"Promis Neurosciences Inc.盘中异动 急速拉升7.22%报11.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607264724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607264724?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:28","pubTimestamp":1769621309,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日01时28分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨7.22%。截至发稿，该股报11.43美元/股，成交量7344股，换手率0.34%，振幅3.66%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129012829a6b834dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129012829a6b834dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2603245485","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603245485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603245485?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:38","pubTimestamp":1768228716,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时38分，Promis Neurosciences Inc.股票出现异动，股价快速上涨7.62%。截至发稿，该股报8.75美元/股，成交量2600股，换手率0.12%，振幅3.81%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223837953c6d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223837953c6d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","BK4139","PMN"],"gpt_icon":0},{"id":"2595795531","title":"Promis Neurosciences Inc.盘中异动 大幅跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595795531?lang=zh_cn&edition=full","pubTime":"2025-12-29 23:10","pubTimestamp":1767021029,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日23时10分，Promis Neurosciences Inc.股票出现波动，股价急速跳水5.35%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229231030a48699c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229231030a48699c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2594400189","title":"Promis Neurosciences Inc.盘中异动 临近午盘股价大涨5.97%报8.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594400189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594400189?lang=zh_cn&edition=full","pubTime":"2025-12-25 00:42","pubTimestamp":1766594558,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日00时42分，Promis Neurosciences Inc.股票出现异动，股价快速上涨5.97%。截至发稿，该股报8.62美元/股，成交量5997股，换手率0.28%，振幅3.32%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225004239a4741aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225004239a4741aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2592145298","title":"Promis Neurosciences Inc.盘中异动 早盘大幅拉升7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592145298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592145298?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:44","pubTimestamp":1766155471,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时44分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨7.10%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219224431953b7573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219224431953b7573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","PMN","BK4139"],"gpt_icon":0},{"id":"1113080391","title":"ProMIS Neurosciences Inc超越预期招募目标，进行Pmn310的精准老年痴呆症阶段1B临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1113080391","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113080391?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:30","pubTimestamp":1766061014,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc超越预期招募目标，进行Pmn310的精准老年痴呆症阶段1B临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"1135888661","title":"ProMIS Neurosciences发布新的同行评审论文，显示血浆Ptau作为阿尔茨海默症试验中的早期预测终点，支持其正在进行的Phase 1B Precise-Ad试验与Pmn310","url":"https://stock-news.laohu8.com/highlight/detail?id=1135888661","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135888661?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:32","pubTimestamp":1764592352,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences发布新的同行评审论文，显示血浆Ptau作为阿尔茨海默症试验中的早期预测终点，支持其正在进行的Phase 1B Precise-Ad试验与Pmn310。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"2580690245","title":"Promis Neurosciences Inc.盘中异动 急速跳水5.44%报0.393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580690245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580690245?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:17","pubTimestamp":1762186659,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时17分，Promis Neurosciences Inc.股票出现波动，股价急速下挫5.44%。截至发稿，该股报0.393美元/股，成交量23.9505万股，换手率0.45%，振幅5.85%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为1.78%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400173994ec81c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400173994ec81c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"1164976537","title":"ProMIS Neurosciences 增强董事会，任命 Slanix Paul Alex 博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1164976537","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164976537?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:31","pubTimestamp":1761132676,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences 增强董事会，任命 Slanix Paul Alex 博士为董事会成员，他是 Ally Bridge Group 的公共股权总裁及投资组合经理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMN","BK4139"],"gpt_icon":0},{"id":"2517574941","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517574941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517574941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:57","pubTimestamp":1741190237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时57分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨6.55%。截至发稿，该股报0.830美元/股，成交量7251股，换手率0.02%，振幅3.90%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","ARFXF","BK4139"],"gpt_icon":0},{"id":"2516598456","title":"Promis Neurosciences Inc.盘中异动 快速跳水12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516598456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516598456?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:25","pubTimestamp":1741022716,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时25分，Promis Neurosciences Inc.股票出现异动，股价急速下跌12.56%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4182.16%、177.33%、156.20%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2514238270","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514238270?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:04","pubTimestamp":1740672240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时04分，Promis Neurosciences Inc.股票出现波动，股价急速下跌6.49%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2512847534","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512847534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512847534?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:36","pubTimestamp":1739983009,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时36分，Promis Neurosciences Inc.股票出现异动，股价急速下跌5.41%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","PMN","ARFXF"],"gpt_icon":0},{"id":"2511452508","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511452508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511452508?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Promis Neurosciences Inc.股票出现异动，股价大幅拉升9.63%。截至发稿，该股报1.000美元/股，成交量2363股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2509220600","title":"Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509220600?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:37","pubTimestamp":1738859853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时37分，Promis Neurosciences Inc.股票出现异动，股价急速上涨5.91%。截至发稿，该股报0.985美元/股，成交量6992股，换手率0.02%，振幅3.23%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"gpt_icon":0},{"id":"2507624281","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507624281?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:49","pubTimestamp":1738248549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时49分，Promis Neurosciences Inc.股票出现波动，股价急速拉升5.12%。截至发稿，该股报0.940美元/股，成交量2028股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"2506305280","title":"Promis Neurosciences Inc.盘中异动 股价大涨10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305280?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:50","pubTimestamp":1737989421,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时50分，Promis Neurosciences Inc.股票出现波动，股价急速上涨10.75%。截至发稿，该股报0.990美元/股，成交量2320股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXF","BK4139","ARFXD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.1625},{"period":"1month","weight":-0.2578},{"period":"3month","weight":0.9243},{"period":"6month","weight":0.4423},{"period":"1year","weight":-0.1577},{"period":"ytd","weight":1.1597}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立。该公司已获得一项专利技术平台的授权，专注于开发针对神经退行性疾病及其他错误折叠蛋白疾病的抗体疗法和治疗性疫苗。其平台旨在选择性靶向与阿尔茨海默病、帕金森病和肌萎缩侧索硬化等疾病相关的毒性错误折叠蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.492325},{"month":2,"riseRate":0.5,"avgChangeRate":0.1186},{"month":3,"riseRate":0,"avgChangeRate":-0.139388},{"month":4,"riseRate":0.666667,"avgChangeRate":0.13153},{"month":5,"riseRate":0,"avgChangeRate":-0.176878},{"month":6,"riseRate":0,"avgChangeRate":-0.154013},{"month":7,"riseRate":0.333333,"avgChangeRate":0.096733},{"month":8,"riseRate":0,"avgChangeRate":-0.185569},{"month":9,"riseRate":0.5,"avgChangeRate":-0.048217},{"month":10,"riseRate":0.25,"avgChangeRate":-0.042317},{"month":11,"riseRate":0,"avgChangeRate":-0.242658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.058437}],"exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}